Last edition
News about "for Non-Cystic Fibrosis Bronchiectasis"
EU Approves Insmed's BRINSUPRI, the First Treatment for Non-CF Bronchiectasis
The European Commission has approved BRINSUPRI as the first treatment for Non-Cystic Fibrosis Bronchiectasis, offering a new option for patients with this serious, progressive lung disease. The first-in-class DPP1 inhibitor was granted accelerated assessment by the EMA, reflecting its significant public health importance.
For Non-Cystic Fibrosis Bronchiectasis | 19/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy